The Synergistic Approach to Peptide Research
Elevate your research with our premium CJC-1295 / Ipamorelin Blend Peptide. This potent combination offers researchers a convenient and highly effective formulation for studying the complex dynamics of Growth Hormone (GH) pulsatility. The vial contains a precise 5mg/5mg ratio of two distinct yet complementary peptides, making it an ideal single-vial solution for investigations requiring concurrent administration of a Growth Hormone Releasing Hormone (GHRH) analog and a potent Growth Hormone Releasing Peptide (GHRP).
Dual-Action Purity for Precision Studies
CJC-1295: Functions as a synthetic analog of GHRH, designed to have an extended half-life. It acts by stimulating the anterior pituitary gland to release GH in a pulsatile manner.
Ipamorelin: A highly selective GHRP that mimics the natural action of Ghrelin, directly stimulating GH secretion with minimal impact on prolactin or cortisol levels, offering a cleaner research profile.
When used together, this blend is often studied for its ability to create a maximized, physiological release of GH, potentially offering a more sustained and robust action than either peptide used alone.
Product Integrity & Specifications
Your research demands the best, and our product delivers:
Compound: CJC-1295 / Ipamorelin Blend
Dosage: 5 MG of CJC-1295 (without DAC) and 5 MG of Ipamorelin per vial.
Total Quantity: 10 MG total lyophilized powder.
Purity: Guaranteed 99% Purity, validated through rigorous quality control to ensure experimental consistency.
Format: Lyophilized powder in a sterile, sealed glass vial for maximum stability.
⚠️ Essential Notice: Research Use Only
This product is strictly intended for in vitro and laboratory research purposes only. It is not intended for human or animal use, consumption, or application in clinical trials. By purchasing, the user confirms they are a qualified researcher or institution and agree to comply with all regulatory guidelines concerning the handling and study of research chemicals.
